Treatment of Antibody-Mediated Renal Allograft Rejection: Improving Step by Step
Throughout the past years we stepwise modified our immunosuppressive treatment regimen for patients with antibody-mediated rejection (ABMR). Here, we describe three consecutive groups treated with different regimens. From 2005 until 2008, we treated all patients with biopsy-proven ABMR with rituxima...
Main Authors: | Nils Lachmann, Michael Duerr, Constanze Schönemann, Axel Pruß, Klemens Budde, Johannes Waiser |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2017/6872046 |
Similar Items
-
Hypertension in Renal Allograft Recipients
by: Waiser Johannes, et al.
Published: (1999-01-01) -
Early eosinophilic antibody-mediated rejection in a renal allograft recipient
by: H Satish, et al.
Published: (2018-01-01) -
Chronic antibody rejection in renal allograft: An underestimated cause of renal allograft dysfunction
by: Nishika Madireddy, et al.
Published: (2019-01-01) -
Cincinnati protocol is not suitable for Indian patients with antibody mediated renal allograft rejection
by: Jasmine Sethi, et al.
Published: (2019-01-01) -
MicroRNA regulation in blood cells of renal transplanted patients with interstitial fibrosis/tubular atrophy and antibody-mediated rejection.
by: Mareen Matz, et al.
Published: (2018-01-01)